Murine myeloid cells can be transformed in vitro by infection with recombinant retroviruses carrying activated myb genes. While these myb-transformed hematopoietic cells (MTHCs) can proliferate continuously in culture, they exhibit several characteristics of progenitor cells of the granulocyte-macrophage (GM) lineage, including an absolute dependence on hematopoietic growth factors (HGFs) such as GM colony-stimulating factor (GM-CSF) for survival and growth. Whereas we have previously shown that MTHCs respond synergistically to certain combinations of HGFs, we report here that MTHCs apparently require two HGFs for proliferation, because GM-CSF alone appears insufficient to promote growth when MTHCs are cultured at very low densities. However, proliferation can be stimu-NFECTION OF PRIMARY CELLS by recombinant retroviruses carrying activated myb genes can transform murine myeloid cells in vitro.'92 These myb-transformed hematopoietic cells (MTHCs) have a number of characteristics ofprogenitor cells of the granulocyte-macrophage (GM) lineage, as shown by previous One such property is their absolute dependence on hematopoietic growth factors (HGFs) for survival and proliferation. Whereas MTHCs can be generated by infection and culture in the presence of a single exogenous HGF such as GM colony-stimulating factor (GM-CSF), we have found that, as reported else~here,~ MTHCs can respond synergistically to certain combinations of HGFs. Those studies were prompted by earlier, preliminary observations that fibroblast feeder layers could enhance the proliferation of recently derived MTHCs, suggesting that the feeder cells produced HGFs that act in collaboration with GM-CSF. We considered that this was of interest because certain fibroblast lines exhibit some of the stimulatory activities of bone marrow (BM) stromal cells on normal hematopoietic cell~.4*~ Therefore, the stimulation of MTHCs by fibroblasts may constitute a simplified model system for studying some aspects of the interactions between stromal and hematopoietic cells. In the present report, we have documented and characterized in detail the effect of feeder layers on MTHC proliferation and have identified a factor essential for their activity as CSF-1 (or M-CSF).
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During the course of these3 and other studies, we also observed a great deal of variability in the plating efficiencies of MTHCs in the presence of GM-CSF in semisolid medium; in particular, the plating efficiency at lower cell densities was often disproportionately low. Similarly, we observed that growth in liquid culture at very low cell densities was also poor. These observations suggested that an additional factor may be essential for the proliferation of MTHCs, and that one such factor may be an autocrine factor produced by the MTHCs, as good growth is seen at higher cell densities. We show here that this is indeed the case; however, the factor responsible does not appear to be CSF-1. Although the autocrine factor has not yet been identified, we suggest that it may represent a novel HGF. lated by either increasing the density at which MTHCs are cultured (implying the production of an autocrine growth factor) or by the presence of a feeder layer of irradiated fibroblasts. We find that the activity of such feeder layers is greatest when the MTHCs are allowed to contact them directly; and by using mutant fibroblast lines, that it depends on the production of CSF-l, but not Steel factor (SLF). In contrast, the autocrine factor appears not to be either CSF-1 or SLF, and the possibility is raised that it may represent a novel HGF activity. Potential implications of these results for normal and leukemic hematopoiesis are discussed. 0 1994 by The American Society of Hematology.
MATERIALS AND METHODS
Generation and maintenance of MTHCs. All MTHCs used in this study were derived by infection of murine fetal liver cells with the RED(CT3myb) retrovirus as described previo~sly.~*'~~ The cells were maintained in the presence of GM-CSF (400 U/mL) and, except where noted, feeder layers of irradiated NIH3T3 cells (see Results for explanation).
Fibroblast cell lines. These were maintained in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal calf serum Collection ofconditioned media. After growing NIH3T3 fibroblasts to 80% confluence, the culture medium was replaced with fresh medium. This was collected after 2 to 3 days, centrifuged and filtered (through a 0.2 wm filter), and stored at 4'C. Conditioned medium from MTHCs was collected 3 days after seeding cells at approximately IO'/mL in GM-CSF-containing medium, followed by processing and storage as above.
Cocultivation of MTHCs and fibroblasts. This was routinely performed in six-well trays (Nunc multidish 6 ; Roskilde, Denmark) with 4 X IO5 fibroblasts that had been irradiated (25 Cy) before plating. MTHCs were added (usually 1,200 or 2,500, as indicated for each experiment) in 2 mL of DMEM containing 20% FCS and 400 U/mL GM-CSF. When necessitated by heavy growth of MTHCs, an additional 2 mL of medium was added. Determination of cell prolikration. All proliferation experiments were performed in duplicate cultures unless otherwise stated, and the data shown are the means of these duplicates. Viable cell numbers were determined by trypan blue exclusion using a hemocytometer after 7 days' growth unless otherwise stated.
Antihndy neutralization. Neutralizing goat antiserum to murine CSF-I was obtained from Dr E.R. Stanley and used at a dilution of 1:2,000.
Detection of dlffiitsible,fuctor.y by agur inlerluyer and dual-chumher experiments. Cocultivations in which contact between fibroblasts and MTHCs was prevented were performed by placing an interlayer ( I mL) of 0.3% agar (in DMEM/20% FCS) over the irradiated fibroblasts in the six-well trays. After setting, MTHCs were added as usual. Dual-chamber experiments were performed by placing inserts containing a 0.4-pm polycarbonate filter (Millicell-CM; Millipore, Bedford, MA) into six-well trays. Varying numbers of MTHCs or 4 X IO5 irradiated NIH3T3 fibroblasts in 2 mL of medium (containing GM-CSF) were placed in the well, ie, outside the insert, and 1,200 MTHCs in 2 mL were placed above the filter, ie, within the insert. MTHCs within and, where added, outside the insert were counted after 7 days.
Analysis of Steel ,factor (SLF) and CSF-l mRNA expreuion. Poly A+ RNA was prepared as described'" and analyzed by formaldehyde-agarose electrophoresis followed by Northern blotting to Hybond-N membranes (Amersham, Arlington Heights, IL) and hybridization to 32P-labeled (Multiprime, Amersham) probes using standard procedures." The probes used were a 2.06-kb Sal I fragment of the murine SLF cDNA (plasmid pBSSK:MGFIO. I ) obtained from Dr D.E. Williams(1mmunex Corp, Seattle) and a 2.1 Ikb Suc I fragment of murine CSF-1 cDNA (plasmid J6/4), obtained from Dr N. Gough (Walter and Eliza Hall Institute, Melbourne, Australia).
RESULTS

Density-dependent growth qf
MTHCs. Figure 1 shows that the proliferation of MTHCs in medium-containing saturating concentrations of GM-CSF increased nonlinearly with the cell density at which the cultures were initiated. Because of the relatively poor proliferation seen at low densities, it seems likely, by extrapolation, that a factor (or factors) additional to GM-CSF is essential for the growth of MTHCs. Moreover, the increase in growth with cell density strongly suggests the production of one such factor by the MTHCs themselves, ie, production of an autocrine growth factor. The density dependence of proliferation shown by the MTHCs is not a nonspecific phenomenon caused, for example, by deficiencies in our culture conditions because other GM-CSF-dependent myeloid cells (the FDC-PI cell line'*) displayed similar rates of proliferation over a range of cell densities (data not shown).
Note that the MTHCs used in this and most of the other experiments described in this report were uncloned lines that had been maintained on "feeder layers" of irradiated NIH3T3 fibroblasts. This was done to avoid selecting subpopulations or clones that have lost their requirement for an additional (ie, in addition to GM-CSF) HGF, because as Stimulation of MTHC proliferation by fibroblast feeder layers. To examine the effect of feeder layers on proliferation, MTHCs were cultured in GM-CSF-containing medium at low density (as defined by experiments such as that illustrated in Fig 1) in the presence of NIH3T3 fibroblasts that had been irradiated to prevent overgrowth ofthe cocultures. Because the MTHCs appeared to adhere quite tightly to the fibroblasts (data not shown), we also examined whether the effect of the fibroblasts was dependent on direct cell-cell contact. This was done by including an interlayer of soft agar medium between the fibroblasts and the MTHCs.
For personal use only. on October 30, 2017. by guest www.bloodjournal.org From gene.I5 and little or no expression was detected in three myeloid cell lines (FDC-PI, WEHI-3B, and 5774). More importantly for the present study, none ofthe five MTHC lines examined expressed detectable SLF mRNA, even on longer exposures (not shown). However, all of the MTHC lines expressed substantial quantities of CSF-I mRNA. These results establish SLF and CSF-I as candidates for the activity produced by fibroblasts, and CSF-I as a candidate for the autocrine factor, but appear to rule out SLF as being responsible for the putative autocrine activity. 
GM alone
Stimulation of MTHC proliferation br fibroblasts. MTHCs were plated at 1,250 cells/l v ir mL taining medium ("GM alone"), in the presence of fibroblasts ("NIH3T3") or both ("NIH3T3 + GM"). Cultures were also set up, as indicated, with an agar interlayer separating the fibroblasts from the MTHCs, as described in Materials and Methods. The total cell number was determined after 7 days' growth; the results of each of the duplicate determinations are shown.
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The results shown in Fig  2 indicate that proliferation of MTHCs was greatly enhanced in the presence of the feeder layer. In this experiment, MTHCs showed only a 3.3-fold increase over 1 week in the absence of the feeder layer but a 738-fold increase in the presence of the fibroblasts. The presence of exogenous GM-CSF had no effect in this or other experiments, presumably because of GM-CSF production by the fibroblasts themselves. Moreover, most of the activity was contact dependent, because the presence of the agar interlayer reduced growth stimulation by 8470 and 8970. respectively, in the absence and presence of added GM-CSF. Nevertheless, it is clear that there is some diffusible activity produced by the fibroblasts because there were still substantial (36-and 25-fold, respectively, in the absence and presence of added GM-CSF) increases in cell numbers compared with the control, ie, without fibroblasts.
Evprcssion of CSF-I and SLF rnRNA.7 byjibroblasts and MTHCs. The experiments described above suggested that both MTHCs and fibroblasts produce activities that can synergize with GM-CSF in stimulating MTHC growth. In our study of HGF responses of MTHCS,~ the only factors that were found to synergize with GM-CSF were CSF-I and SLF. Therefore, we examined the expression of these factors by Northern blotting (Fig 3) . It was not surprising that NIH3T3 fibroblasts and another murine embryonic fibroblast line, WCB6FI-3T3 +/+, expressed mRNA for both CSF-l and SLF, based on previous data on murine fib rob last^.'"^.'^ Again as expected. mRNA for the latter factor was not expressed in the WCB6FI-3T3 Sl/Sl Steel mutant fibrob l a s t~*~'~ because the SI mutation is a deletion in the SLF Ability of mutant fibroblast lines to promote MTHCproliferation. A potentially powerful approach to the identification of the activities produced by the fibroblast feeder layers is to exploit the availability of well-characterized mutations in particular mouse strains that eliminate production of each of the two candidate HGFs, SLF and CSF-1. To this end, we tested the ability of fibroblasts from Steel mutant mice for their ability to support MTHC proliferation. Figure 4 shows that fibroblasts from Sl/Sl mice, which produce no functional SLF,'' and from Sl/Sld mice, which produce only a soluble form of SLF,I6 both promote MTHC proliferation to a similar degree to congenic +/+ and NIH3T3 fibroblasts. Therefore, it can be concluded that SLF is not responsible or required for the stimulatory effect of fibroblast feeder layers.
Mice homozygous for the op mutation cannot synthesize functional CSF-l*' because of a point mutation in the coding sequence that results in premature termination of translation.'8 Therefore, we tested op/op fibroblast lines and, as a control, op/+ lines, for their ability to support MTHC proliferation. The results of the experiments depicted in Fig 5 clearly show that the homozygous mutant fibroblasts were incapable of stimulating MTHC proliferation above control levels, whereas the heterozygous cells exhibited similar activity to NIH3T3 fibroblasts. Thus, these data imply that CSF-1 production is essential for the ability of fibroblasts to promote the proliferation of MTHCs.
Neutralization of diffusible but not contact-mediated stimulatory activities of fibroblasts by CSF-1 antiserum.
MACMILLAN AND GONDA
In an attempt to confirm that the stimulatory effect of NIH 3T3 fibroblasts on MTHC proliferation was also caused by CSF-1, a neutralizing antibody was added to cocultures of the two cell types. However, we did not observe any significant or reproducible inhibition of MTHC growth over a series of many experiments such as that illustrated in Fig 6A. One possible explanation for this apparent discrepancy with the results obtained using the op/op fibroblasts was that the antiserum may not be effective in blocking interactions between MTHCs and fibroblasts in close contact. To circumvent this potential complication, the ability ofthe antiserum to inhibit the diffusible activity produced by NIH3T3 cells was tested. Diffusible activity that synergized with GM-CSF in supporting MTHC proliferation could be detected both when the MTHCs were separated from the fibroblasts by an agar interlayer as described above (see Fig 2) and when conditioned medium from fibroblasts was added to MTHCs (Fig 6 A and B) . Figures 6A and 6B also indicate that the diffusible activity produced by NIH3T3 fibroblasts was largely, but in some cases not entirely, blocked by the anti-CSF-l antiserum. (Note that the data also indicate that the antiserum is functional; this was further confirmed by its ability to inhibit the stimulation seen on addition of recombinant murine CSF-1 [Fig 6Bl. ) These results confirm that CSF-l is at least an essential component of the diffusible activity produced by NIH3T3 cells in addition to being essential for any activity of the lung fibroblast lines discussed in the preceding section. However, although the activity in conditioned medium was somewhat variable, it was, like the activity seen in the agar interlayer experiments (Figs 6A and 2), always substantially less than that obtained by direct coculture (Fig 6A) . Consistent with these data is the observation that recombinant CSF-1 (2,500 U/mL) could not fully substitute for the presence of fibroblasts in direct contact with the MTHCs (Fig 6C) , even though it did stimulate proliferation in concert with GM-CSF (Fig 6, C and B) . The data shown in Fig 6C also suggest that stimulation by CSF-1 is more effective at a higher cell density, ie, that CSF-l and the autocrine activity (see below) may act additively or synergistically, although this observation needs further confirmation.
The autocrine activity produced by MTHCs is not CSF-1. The finding that CSF-l is (at least) an essential component of the GM-CSF-synergistic activity produced by fibroblasts,
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together with the Northern blot data of Fig 3, again raised the possibility that the autocrine activity produced by MTHCs was also CSF-1. To test this, and to determine whether the activity produced by the MTHCs was diffusible, we initially used a two-chamber assay system in which MTHCs at high density (2.5 X lo4 mL) were separated by a 0.4 pm filter from cells at a low density (6 X 10' mL). Antiserum to CSF-1 was included in some cases, and as a control, the MTHCs at high density were replaced by NIH3T3 cells. The results displayed in Fig 7 show that the MTHCs do indeed produce a diffusible activity, because the presence of MTHCs at high density in the outer chamber resulted in a 4 1 -fold stimulation of growth compared with the control where cells were at the same low density in both chambers. The increase in cell number is roughly equivalent to that of the MTHCs placed at high density in the outer chamber (49-fold; data not shown), but is less than that produced when NIH3T3s were plated on the bottom of the outer chamber. Most importantly, though, the activity generated by the MTHCs was not affected by the presence of the CSF-1 antiserum, whereas the activity produced by the fibroblasts was, as before, largely blocked (by 90% in this experiment; note the logarithmic scale).
Finally, to confirm these observations, conditioned medium produced by MTHCs cultured at high density in the presence of GM-CSF was tested for its ability to stimulate proliferation of MTHCs cultured initially at low cell density. Figure 8 shows that increasing stimulation was observed when the proportion of conditioned medium was For varied over the range 2% to 50% (vol/vol). Again, as would be expected from the experiment shown in Fig 7, this activity was unaffected by the presence of anti-CSF-1 antiserum.
Thus, MTHCs produce a diffusible factor that stimulates proliferation in the presence of GM-CSF and that is distinct from CSF-1.
DISCUSSION
The results presented here confirm and extend our findings which indicate that MTHCs respond synergistically to certain combinations of HGFs.~ In particular, they imply that MTHCs may absolutely require a second HGF, and that the proliferation seen in the apparent absence of additional HGFs is probably caused by the production of an autocrine factor. Whereas CSF-I and SLF can act to stimulate MTHCs at low density in conjunction with GM-CSF, it is unlikely that either ofthese are responsible for the autocrine activity. This can be deduced from the following three observations: ( I ) MTHCs do not express SLF mRNA; (2) neither CSF-1 nor SLF added exogenously to low-density cultures can promote growth equivalent to that seen in highdensity cultures or on addition of MTHC-conditioned medium (Fig 6C and data not shown) ; and (3) antibodies to CSF-l do not affect the autocrine activity. It may be, though, that CSF-l can act synergistically with this autocrine factor and GM-CSF because we have observed increased proliferation when CSF-1 is added to MTHC-conditioned medium (Fig 6C and data not shown) .
What is the identity ofthe "autocrine factor"? Because ( I ) other than CSF-l and SLF, none of a wide range of HGFs including interleukins (ILs) 1, 3, 4, 5, 6 , and I l, as well as MACMILLAN AND GONDA G-CSF and leukemia inhibitory factor, that have been tested for their ability to synergise with GM-CSF in supporting MTHC proliferation3 (and data not shown) has proven positive, and (2) the autocrine factor is unlikely to be either CSF-1 or SLF (see above), it is tempting to speculate that it may represent a novel factor. Although further characterization and, ultimately, purification will be necessary to support such a notion, it is of interest to consider some of the implications of an autocrine factor being produced by MTHCs. First, it seems unlikely that it acts only on cells transformed by rnyb, as it is difficult to envisage that transformation could induce a requirement in these cells for a factor that is not needed by their normal "parents." Secondly, it is not unreasonable to suggest that normal hematopoietic progenitor cells (to which MTHCs are similar in a number of re~pects,~ and which express c-myh) may also produce the autocrine factor, in which case it could play a role in situations where normal progenitor cells are at relatively high density, eg, in the marrow. In this light, it will be of interest to determine whether MTHC-conditioned medium acts on normal progenitor cells in the presence ofGM-CSF or other HGFs. Alternatively, elevated levels of the autocrine factor may be produced as a consequence of transformation by rnyb, which would raise the further possibility that its expression is directly regulated by the Myb protein (which is a transcription factor".*'). In this case, production of the factor may be relevant to the mechanism of transformation by mvh.
The other activity identified in this study that synergizes with GM-CSF in stimulating MTHC proliferation is produced by fibroblasts of both murine and human (unpublished observations, May 1992) origin. It is clear that CSF-I is an essential component of this activity based on genetic (op/op) and antibody-neutralization data. However, the activity cannot be accounted for solely by secreted CSF-1 because ( l ) the activity of the fibroblasts is substantially reduced if cell-cell contact is prevented, and (2) addition of recombinant CSF-1 is far less effective than coculture with fibroblasts. One potential explanation is that the ability of fibroblast cocultures to maximally stimulate MTHC proliferation is caused by the presence of the membrane-bound form of CSF-1 *I on these cells. It has already been shown that membrane-bound CSF-I can stimulate normal macrophage progenitors,** but there are currently no data available that address the relative efficacies of the membranebound and secreted forms. Nevertheless, SLF, which also is produced in secreted and membrane-bound form^,'^.'^ provides a precedent which indicates that the activities of the membrane-bound and secreted forms of an HGF may differ. The idea that the membrane-bound form is more effective is implied by the phenotype of the Sf mutation that prevents production of the membrane-bound form of SLF.I6 Mice of the Sl/Sp genotype have hematopoietic def e c t~,~~ and fibroblast cell lines as well as BM stroma from these animals have an impaired ability to support proliferation of hematopoietic ~e l l s .~.~, '~ Moreover, a direct comparison of fibroblasts expressing the two forms has shown significant quantitative and qualitative differencesz5 Thus. by analogy, it is possible that membrane bound CSF-1 may be For personal use only. on October 30, 2017 . by guest www.bloodjournal.org From quantitatively more effective in stimulating proliferation. The MTHC/fibroblast system described here should prove valuable for exploring the roles of the various forms of CSF-1 by introducing the corresponding cDNAs into op/op fibroblasts and comparing their abilities to stimulate the proliferation of MTHCs.
In any case, our studies highlight the possibility that CSF-1, and perhaps its membrane-bound form in particular, may play an important role in normal stromal cell-driven hematopoiesis. CSF-l is known to synergize with other HGFs including GM-CSF and IL-3 in stimulating the proliferation of primitive hematopoietic progenitors termed high proliferative-potential colony-forming cells.26 Moreover, in addition to the macrophage deficiency seen in op/op mice,27 the number of GM progenitors is reduced in these mice, as is the number of day 1 1 spleen colony-forming units.28 This is consistent with a role for CSF-l in the proliferation and/or generation of progenitor and "stem" cells in vivo. By analogy with SLF, it may be that the membrane-bound form plays a particularly important role in this facet of CSF-1 activity.
However, we cannot rule out other explanations for our observations regarding the stimulation of MTHC proliferation by fibroblasts. The data presented here do not formally link the requirements for CSF-l production and cell-cell contact, so it may be that (soluble) CSF-1 acts in concert with a yet-unidentified membrane-bound or extracellular matrix-associated activity, or possibly with signals generated by interaction with the extracellular matrix per se. Many instances of associations between growth factors and extracellular matrix or membranes have been documented. 29 Finally, as we have pointed out previou~ly,~ MTHCs may also comprise a useful model system for studying acute myeloid leukemias (AMLs), because the latter also resemble continuously proliferating GM progenitors that fail to differentiate (at least in vivo) and require HGFs for the usually limited proliferation they display in vitro. 30 The results presented here point to the possibility that combinations of synergisitically acting factors may be necessary for the continued proliferation of AML cells, and suggest that CSF-l and/or potential autocrine factors may be candidates for such activities.
